Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Alzheimer’s disease-linked protease BACE1 modulates neuronal IL-6 signaling through shedding of the receptor gp130
Stephan A. Müller, Merav D. Shmueli, Xiao Feng, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Targeting IL-6 trans-signalling: past, present and future prospects
Stefan Rose‐John, Brendan J. Jenkins, Christoph Garbers, et al.
Nature reviews. Immunology (2023) Vol. 23, Iss. 10, pp. 666-681
Open Access | Times Cited: 249
Alzheimer’s disease and its treatment–yesterday, today, and tomorrow
A. Y. Kim, Salman Al Jerdi, Ryan B. MacDonald, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 21
Roles of Cytokines in Alzheimer’s Disease
Zilin Chen, Yekkuni L. Balachandran, Wai Po Chong, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5803-5803
Open Access | Times Cited: 17
Safety concerns associated with BACE1 inhibitors - past, present and future
Aniketh Naidu, Bret Silverglate, Mary Silverglate, et al.
Expert Opinion on Drug Safety (2025)
Closed Access | Times Cited: 2
Long-term increase in soluble interleukin-6 receptor levels in convalescents after mild COVID-19 infection
Juliane Lokau, Yvonne Garbers, Manuel M. Vicente, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 1
Advancements and Challenges in Antiamyloid Therapy for Alzheimer’s Disease: A Comprehensive Review
Semira Abdi Beshir, Nadia Hussain, Vineetha Bharathan Menon, et al.
International Journal of Alzheimer s Disease (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 6
Gamma-secretase modulators: a promising route for the treatment of Alzheimer's disease
Gunnar Nordvall, Johan Lundkvist, Johan Sandin
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 15
Molecular insights into myelomeningocele via proteomic analysis of amniotic fluid
Lucie Guilbaud, Kévin Roger, Andree Schmidt, et al.
Journal of Proteomics (2025) Vol. 313, pp. 105372-105372
Closed Access
Factores solubles del sistema inmune: clasificación y mecanismos de acción
José Sanz, R. Sánchez Martín, E. Castillo Ruiz, et al.
Medicine - Programa de Formación Médica Continuada Acreditado (2025) Vol. 14, Iss. 28, pp. 1673-1687
Closed Access
Shedding new light on BACE1-mediated modulation of IL-6 signaling: Implications for neural activity and synaptic plasticity in mice
Beate Franke, Kai K. Kummer, Stefan Rose‐John, et al.
Cytokine (2025) Vol. 190, pp. 156925-156925
Closed Access
The effects of weight training and Aklil-ol-Malek on histopathology and C-Reactive Protein, Nuclear Factor Erythroid-Derived 2-Like 2Beta-Site Amyloid Precursor Protein Cleaving Enzyme1 genes Expression in Alzheimer’s disease model rats
Farah Nameni, Mohammad Reza Amir Khan Dehkordi
Journal of Neurorestoratology (2025), pp. 100206-100206
Open Access
BACE1 regulates sleep–wake cycle through both enzymatic and non–enzymatic actions
Hannah Heininger, Xiao Feng, Alp Altunkaya, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
The Alzheimer’s disease-linked protease BACE2 cleaves VEGFR3 and modulates its signaling
Andree Schmidt, Brian Hrupka, Frauke van Bebber, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 16
Open Access | Times Cited: 3
β-Secretase-1: In Silico Drug Reposition for Alzheimer’s Disease
Roberto A. Galeana-Ascencio, Liliana Mendieta, Ilhuicamina Daniel Limón, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8164-8164
Open Access | Times Cited: 7
Molecular Dynamics and Binding Energetics of Fluspirilene With BACE1: Implications for Alzheimer's Disease Intervention
Kunal Bhattacharya, Atanu Bhattacharjee, Manodeep Chakraborty, et al.
Peptide Science (2024) Vol. 116, Iss. 4
Closed Access | Times Cited: 2
Associations of CSF BACE1 with amyloid pathology, neurodegeneration, and cognition in Alzheimer’s disease
Feng Gao, Mengguo Zhang, Qiong Wang, et al.
Acta Neuropathologica (2024) Vol. 147, Iss. 1
Closed Access | Times Cited: 2
Microglia Signaling in Health and Disease – Implications in Sex-Specific Brain Development and Plasticity
Subrata Pramanik, Hyde Thomas M, Saswata Chakrabarty, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 165, pp. 105834-105834
Closed Access | Times Cited: 2
Multicolor, Cell-Impermeable, and High Affinity BACE1 Inhibitor Probes Enable Superior Endogenous Staining and Imaging of Single Molecules
Florian Stockinger, Pascal Poc, Alexander Möhwald, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 12, pp. 10152-10167
Open Access | Times Cited: 1
Exploring the role of interleukin-6 receptor blockade in epilepsy and associated neuropsychiatric conditions through a mendelian randomization study
Yanmei Yu, G Z Jin, Chong Zhong, et al.
World Journal of Psychiatry (2024) Vol. 14, Iss. 8, pp. 1244-1253
Closed Access | Times Cited: 1
High-Throughput Preclinical Models and Pharmacoproteomics
Vipul Prajapati, Malika Verma, G. Santhana Kumar, et al.
(2024), pp. 429-468
Closed Access | Times Cited: 1
BACE Inhibitor Clinical Trials for Alzheimer’s Disease
Elyse Watkins, Robert Vassar
Journal of Alzheimer s Disease (2024) Vol. 101, Iss. s1, pp. S41-S52
Closed Access | Times Cited: 1
Contribution of amyloid deposition from oligodendrocytes in a mouse model of Alzheimer’s disease
Akihiro Ishii, Joseph Pathoulas, Omar M. Omar, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Discovery of an APP-Selective BACE1 Inhibitor for Alzheimer’s Disease
Jesus Campagna, Barbara Jagodzinska, Dongwook Wi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
The Biology of Interleukin-6: A Major Target in Anti-Inflammatory Therapies
Stefan Rose‐John
Elsevier eBooks (2024)
Closed Access
Microfluidics in neural extracellular vesicles characterization for early Alzheimer's disease diagnosis
Hossein Zare, Michelle M Kasdorf, Amirala Bakhshian Nik
Molecular and Cellular Neuroscience (2024) Vol. 132, pp. 103982-103982
Closed Access
Page 1 - Next Page

Scroll to top